Expert analysis and insights on markets from our team of specialists.
Neuren shares fell when Europe knocked back its treatment for a rare childhood disease, then jumped when the regulator changed its mind. Here's how it played out.
4DMedical was the ASX’s best-performing healthcare stock through the last financial-year close. It’s on a run that traces back to the day Pro Medicus backed...
Were things really better in Australia's 'good old days'? A team of economists put it to the test with their data. While the answer is…
CSL has bounced hard off its lows, and some are already buying back in. But one broker says it's his 'most likely to disappoint'.
Feeling gloomy about the future? You’re not alone. New data shows economic pessimism is growing in Australia, and the implications reach far beyond the hip…
The standout new listing to watch right in the coming days might just be this little-known Italian web company. Meet Bending Spoons
The Federal Reserve, under pressure from President Donald Trump to cut interest rates and bend to his will, just got an important assist from the…
What's behind this increased desire from the world's central banks to hold physical gold bullion?
PM Anthony Albanese has doubled fines for social giants breaching the social media ban to $99m. Here's why it risks attracting additional Trump tariffs.
Most experts agree that - for now, at least - the Reserve Bank that has finished hiking interest rates. KPMG chief economist Brendan Rynne told…